Webster Bank’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-36
| Closed | -$6.6K | – | 703 |
|
|
2026
Q1 | $6.6K | Hold |
36
| – | – | ﹤0.01% | 552 |
|
|
2025
Q4 | $6.34K | Hold |
36
| – | – | ﹤0.01% | 538 |
|
|
2025
Q3 | $5.04K | Hold |
36
| – | – | ﹤0.01% | 559 |
|
|
2025
Q2 | $4.52K | Hold |
36
| – | – | ﹤0.01% | 547 |
|
|
2025
Q1 | $4.93K | Sell |
36
-39
| -52% | -$5.58K | ﹤0.01% | 528 |
|
|
2024
Q4 | $11.5K | Hold |
75
| – | – | ﹤0.01% | 473 |
|
|
2024
Q3 | $14.5K | Hold |
75
| – | – | ﹤0.01% | 458 |
|
|
2024
Q2 | $17.4K | Hold |
75
| – | – | ﹤0.01% | 442 |
|
|
2024
Q1 | $16.2K | Hold |
75
| – | – | ﹤0.01% | 440 |
|
|
2023
Q4 | $19.4K | Hold |
75
| – | – | ﹤0.01% | 429 |
|
|
2023
Q3 | $19.3K | Hold |
75
| – | – | ﹤0.01% | 405 |
|
|
2023
Q2 | $21.4K | Hold |
75
| – | – | ﹤0.01% | 394 |
|
|
2023
Q1 | $20.9K | Buy |
75
+36
| +92% | +$9.96K | ﹤0.01% | 413 |
|
|
2022
Q4 | $11K | Hold |
39
| – | – | ﹤0.01% | 449 |
|
|
2022
Q3 | $10K | Hold |
39
| – | – | ﹤0.01% | 450 |
|
|
2022
Q2 | $8K | Hold |
39
| – | – | ﹤0.01% | 466 |
|
|
2022
Q1 | $8K | Hold |
39
| – | – | ﹤0.01% | 486 |
|
|
2021
Q4 | $9K | Hold |
39
| – | – | ﹤0.01% | 490 |
|
|
2021
Q3 | $11K | Hold |
39
| – | – | ﹤0.01% | 470 |
|
|
2021
Q2 | $14K | Hold |
39
| – | – | ﹤0.01% | 435 |
|
|
2021
Q1 | $11K | Hold |
39
| – | – | ﹤0.01% | 461 |
|
|
2020
Q4 | $10K | Hold |
39
| – | – | ﹤0.01% | 451 |
|
|
2020
Q3 | $11K | Hold |
39
| – | – | ﹤0.01% | 417 |
|
|
2020
Q2 | $10K | Hold |
39
| – | – | ﹤0.01% | 414 |
|
|
2020
Q1 | $12K | Hold |
39
| – | – | ﹤0.01% | 395 |
|
|
2019
Q4 | $12K | Hold |
39
| – | – | ﹤0.01% | 429 |
|
|
2019
Q3 | $9K | Hold |
39
| – | – | ﹤0.01% | 445 |
|
|
2019
Q2 | $9K | Hold |
39
| – | – | ﹤0.01% | 441 |
|
|
2019
Q1 | $9K | Hold |
39
| – | – | ﹤0.01% | 433 |
|
|
2018
Q4 | $12K | Hold |
39
| – | – | ﹤0.01% | 403 |
|
|
2018
Q3 | $14K | Buy |
+39
| New | +$13.4K | ﹤0.01% | 425 |
|
|
2017
Q1 | – | Sell |
-6
| Closed | -$2K | – | 569 |
|
|
2016
Q4 | $2K | Buy |
+6
| New | +$1.78K | ﹤0.01% | 570 |
|
Other funds holding BIIB
Webster Bank's BIIB Position: Q2 2026 in Review
Webster Bank sold out of Biogen (BIIB) in Q2 2026, closing a stake of 36 shares — an estimated $6.6K sold.
Webster Bank first reported a position in BIIB in Q4 2016 and held it in 32 quarters. The position peaked at $21.4K in Q2 2023. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Webster Bank reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
- Webster Bank sold 36 Biogen shares in Q2 2026, an estimated $6.6K.
- Webster Bank first reported a position in Biogen in Q4 2016 and held it in 32 quarters.
- Webster Bank's Biogen position peaked at $21.4K in Q2 2023.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Webster Bank's 13F filing for Q2 2026, filed 20 Jul 2026.